Tech Times on MSN
GE HealthCare pays $945M for PET tracer network that radioactive decay made irreplaceable
GE HealthCare agreed to acquire SOFIE Biosciences for $945 million, targeting SOFIE's 21-cyclotron US manufacturing network.
DULLES, Va., Dec. 29, 2025 /PRNewswire/ -- SOFIE Biosciences, an established U.S. manufacturer and developer of radiopharmaceuticals, today announced that the first patient has been dosed in one of ...
Stocktwits on MSN
GE HealthCare to acquire SOFIE Biosciences for $945M — here’s what GEHC investors need to know
SOFIE will continue serving its existing customers, including other radiopharmaceutical providers, following the deal. ・The transaction includes 15 CMO sites and 21 cyclotrons across SOFIE’s U.S.
DULLES, Va., May 12, 2023 /PRNewswire/ -- SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged the first patient with [18 F]FAPI-74 in ...
DULLES, Va., Nov. 29, 2022 /PRNewswire/ -- SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has received Investigational New Drug (IND) clearance to ...
DULLES, Va., Feb. 11, 2026 /PRNewswire/ -- SOFIE Biosciences, an established U.S. manufacturer and developer of radiopharmaceuticals, today announced that the first patient has been dosed in the ...
SOFIE Biosciences, an established US manufacturer and developer of radiopharmaceuticals, announced that the first patient has been dosed in the second of its two phase 3 clinical trials evaluating 18F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results